Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial.

Atsushi TanakaMichio ShimabukuroNoritaka MachiiHiroki TeragawaYosuke OkadaKosuke Robert ShimaToshinari TakamuraIsao TaguchiItaru HisauchiShigeru ToyodaYasushi MatsuzawaHirofumi TomiyamaMinako Yamaoka-TojoHisako YoshidaYasunori SatoYumi IkeharaShinichiro UedaYukihito Higashi Koichi Nodenull null

Published in: Diabetes care (2019)

Keyphrases

double blind
placebo controlled
phase iii
cardiovascular disease
phase ii
clinical trial
study protocol
phase ii study
type diabetes
open label
cardiovascular events
randomized controlled trial
cardiovascular risk factors
metabolic syndrome
cross sectional